Important: This article provides general information and does not replace diagnosis or individualized medical nutrition therapy. People with disease, medication use, pregnancy, childhood needs, unintentional weight loss, or other special requirements should be assessed by a qualified health professional.

Personal nutrition does not have to begin with an expensive test

Personalized nutrition is often discussed alongside genetics, microbiome science, and artificial intelligence. In routine practice, however, personalization begins with more basic but powerful information: diagnoses, medicines, laboratory findings, eating habits, symptoms, culture, budget, work patterns, cooking access, and readiness to change. These factors directly shape both safety and feasibility.

Precision nutrition aims to extend that framework through biological measurements, multi-omic data, and predictive algorithms. The US National Institutes of Health Nutrition for Precision Health program is studying interactions among genes, proteins, metabolism, the microbiome, and contextual factors to develop algorithms that predict individual responses. The scale of this ongoing research effort reflects both the field's potential and the number of questions still unresolved.

Figure 1Four links that turn personal data into useful advice
  1. Valid dataIs the measurement accurate, and is it reasonably reproducible under comparable conditions?
  2. Meaningful interpretationIs the finding merely statistically different, or clinically important for this person?
  3. An actionable decisionDoes it produce a different and better decision than standard evidence-based advice?
  4. A monitored outcomeIs the change safe, followed in practice, and actually improving a measured health outcome?

If any link is missing, personal-looking data may fail to become personally useful advice.

Why is more data not always better?

An interesting measurement is not necessarily reliable enough to change a dietary decision. Biological data may be sensitive to time of day, the previous meal, sleep, physical activity, medicines, infection, sampling method, and analytical platform. An association between a variable and disease also does not prove that tailoring a diet to that variable prevents or treats the disease.

Clinical value is determined by added benefit, not data volume. If the same decision can already be reached through dietary history, appropriate laboratory results, and a careful consultation, an expensive test may add little. By contrast, accurate clinical data in coeliac disease, kidney disease, diabetes, food allergy, or malnutrition can materially change a plan's safety. Personalization sometimes means asking the right person the right question rather than using advanced technology.

Genetic tests: biologically interesting, not always clinically decisive

Genes can influence nutrient metabolism and differences in response between individuals. Common obesity, glycaemic response, and weight-loss success, however, are rarely explained by one variant. Many genes interact with lifestyle, environment, and behavior. Measuring a small panel of variants and declaring one uniquely suitable diet therefore often goes beyond the evidence.

In Food4Me, online personalized advice improved dietary behavior more than general advice, but adding phenotype and genotype information did not increase the effect. In DIETFITS, the tested genotype pattern did not identify whether a healthy low-fat or healthy low-carbohydrate diet would produce more weight loss over 12 months. These results do not mean genetics is irrelevant; they show that limited current test panels cannot usually determine diet choice on their own.

Microbiome analysis: one snapshot of a moving ecosystem

The gut microbiome has a two-way relationship with diet, and research suggests substantial potential. Yet its composition can vary with diet, medicines—especially antibiotics—geography, intestinal transit time, sample storage, and analytical method. Commercial platforms may also classify and interpret the same sample differently.

A 2025 international consensus statement set minimum requirements for analytical and clinical validity, standardization, and interpretation, while highlighting evidence and actionability gaps in many direct-to-consumer tests. Linear conclusions such as ‘this bacterium is low, therefore take this supplement’ often fail to represent ecosystem complexity. A result should not be treated as a validated diagnosis or a personalized treatment prescription.

What do wearables and continuous glucose monitoring add?

Wearables can reveal patterns in daily life rather than relying on a single laboratory measurement. PREDICT and earlier studies showed that the same meal can produce different post-meal glucose and triglyceride responses across individuals. Sleep, physical activity, meal timing, and the previous meal may also influence that response. This variability explains the appeal of personal feedback.

A sensor still shows only the variable it measures. One glucose rise does not prove that a food is wholly ‘bad’, and a flatter curve does not establish high overall nutritional quality. Fibre, protein, micronutrients, satiety, longer-term lipid responses, and total dietary pattern cannot be reduced to one curve. CGM has established clinical uses in diabetes; the long-term value of consumer use to score individual foods in everyone without diabetes is not supported by equally strong evidence.

Figure 2How useful are different kinds of personalization data today?

Clinical status and context

Diagnosis, medicines, laboratory results, symptoms, budget, and culture directly inform safety and feasibility today.

Diet and behavior data

Habits, preferences, and barriers shape personal goals; follow-up adapts advice to real life.

Sensors and metabolic response

Potentially powerful in selected clinical settings; one biomarker does not represent total diet quality.

Genetics and microbiome

Research potential is high, but routine outcome-improving action remains limited for many commercial results.

This is not an argument against technology: the value of data depends more on added decision and outcome benefit than on novelty.

Intervention studies do not give one simple answer

Personalized advice may improve motivation and adherence. In Food4Me, personal feedback improved dietary behavior compared with general advice, yet adding more complex biological information did not increase the benefit. Some of the effect may therefore come from receiving relevant personal attention and feedback rather than from advanced biology alone.

In the six-month Personal Diet Study, an algorithm-personalized diet designed to reduce post-meal glucose response did not produce greater weight loss than a standardized low-fat diet. In contrast, the 18-week METHOD trial in 2024 used microbiome data, post-meal responses, and health history and reported improvements in triglycerides, weight, waist circumference, HbA1c, and some secondary outcomes compared with general advice. There was no group difference in LDL cholesterol—one of two primary outcomes—or in several other metabolic measures. Because the program was multi-component, the benefit cannot be cleanly attributed to one test, algorithm, app feature, or the greater adherence reported by participants.

The evidence supports neither ‘personalized nutrition does not work’ nor ‘everyone needs biological testing’. A more defensible conclusion is that personal feedback can help, selected biological data may add value for selected people, and the superiority of expensive, complex personalization over high-quality standard nutrition care has not been established for every method or outcome.

Questions to ask before buying a test or personalized nutrition program

  • Has the test's analytical accuracy and within-person reproducibility been demonstrated?
  • What decision will the result change beyond standard advice?
  • Do randomized trials show that acting on this result improves a clinical outcome?
  • Will the result be interpreted by a qualified health professional in the relevant field?
  • What follow-up exists for an unfavorable, uncertain, or conflicting result?
  • Who can access genetic, microbiome, or sensor data, and how long will it be retained?

What does strong personalization look like today?

The strongest starting point is to define the person's actual need: weight loss, glycaemic management, symptom control, malnutrition prevention, or sports performance. Diagnoses and medicines, appropriate laboratory and anthropometric data, dietary history, eating behavior, and social circumstances are then evaluated together. Advice is built around the person's preferences, translated into feasible goals, and revised according to outcomes.

Genetic, microbiome, or sensor data should enter this chain only when measurement is reliable, interpretation is supported by sufficient evidence, and the information will genuinely change a decision. Good personalization is not collecting the largest possible dataset; it is excluding unnecessary data and using the right information at the right time.

Take-home message

Advice becomes personal not because its data are technologically advanced, but because it produces safe, measurable benefit for the person.

Genetics, microbiome science, and wearables may become central to the future of nutrition. Today they should be used with clinical context and human judgment, without allowing technological promise to outrun evidence.

Scientific sources

  1. National Institutes of Health Common Fund. Nutrition for Precision Health, powered by the All of Us Research Program. Last reviewed 27 May 2026.
  2. Celis-Morales C, et al. Effect of personalized nutrition on health-related behaviour change: evidence from the Food4Me European randomized controlled trial. International Journal of Epidemiology, 2017.
  3. Gardner CD, et al. Effect of Low-Fat vs Low-Carbohydrate Diet on 12-Month Weight Loss and the Association With Genotype Pattern or Insulin Secretion: The DIETFITS Randomized Clinical Trial. JAMA, 2018.
  4. Zeevi D, et al. Personalized Nutrition by Prediction of Glycemic Responses. Cell, 2015.
  5. Berry SE, et al. Human postprandial responses to food and potential for precision nutrition. Nature Medicine, 2020.
  6. Popp CJ, et al. Effect of a Personalized Diet to Reduce Postprandial Glycemic Response vs a Low-fat Diet on Weight Loss in Adults With Abnormal Glucose Metabolism and Obesity. JAMA Network Open, 2022.
  7. Bermingham KM, et al. Effects of a personalized nutrition program on cardiometabolic health: a randomized controlled trial. Nature Medicine, 2024.
  8. Porcari S, et al. International consensus statement on microbiome testing in clinical practice. The Lancet Gastroenterology & Hepatology, 2025.